GGrantIndex
← Leaderboards

S. Claiborne Johnston

University Of California San Francisco

Google Scholar ↗PubMed ↗ORCID ↗
$90,628,870
Attributed
$98,432,867
Total exposure
25
Grants
23
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $52.7M · FY2005–17
$100M$75M$50M$25M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17

Funding mix

By agency

NIH$245,447,952 · 28

By mechanism

UL1$154,503,939 · 17
U01$67,753,780 · 2
KL2$20,788,640 · 5
TL1$1,687,173 · 2
K02$608,850 · 1
K08$105,570 · 1

Top collaborators

Most similar at University Of California San Francisco

Same institution · by research overlap

Others in their field

Top investigators on “Research Infrastructure”

Research focus

Research InfrastructureTranslational ResearchInstitutesCollaborationsInnovationClinical ResearchResearch PersonnelBasic ScienceEnvironmentCaliforniaCommunitiesSan FranciscoInstitutionProgramsClinical TrialsUniversitiesMissionTrainingRewardsCommunicationParticipantMultidisciplinaryFosteringServices

Grant awards (55)

POINT: PLATELET-ORIENTED INHIBITION IN NEW TIA$11,826,732
U01 · FY2017 · NS · contact PI
ConProject-001$11,705,995
U01 · FY2017 · NS · contact PI
POINT: Platelet-Oriented Inhibition in New TIA$3,434,132
U01 · FY2016 · NS
POINT: Platelet-Oriented Inhibition in New TIA$7,772,710
U01 · FY2015 · NS
POINT: Platelet-Oriented Inhibition in New TIA$6,301,494
U01 · FY2013 · NS
POINT: Platelet-Oriented Inhibition in New TIA$6,000,000
U01 · FY2013 · NS · contact PI
Clinical and Translational Science Institute$18,994,467
UL1 · FY2012 · TR · contact PI
POINT: Platelet-Oriented Inhibition in New TIA$8,288,178
U01 · FY2012 · NS · contact PI
Clinical and Transtional Science Institute$3,195,734
KL2 · FY2012 · TR · contact PI
Engaging University of California Stakeholders for Biorespository Research$2,018,277
UL1 · FY2012 · TR · contact PI
A New CTSA Partnership to Translate an Oral Cancer Biomarker from Lab to Clinic$492,690
UL1 · FY2012 · TR · contact PI
Clinical and Transtional Science Institute$335,724
TL1 · FY2012 · TR · contact PI
Clinical and Translational Science Institute$18,818,622
UL1 · FY2011 · RR · contact PI
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS$8,177,086
UL1 · FY2011 · RR · contact PI
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCH$5,611,592
UL1 · FY2011 · RR · contact PI
Clinical and Transtional Science Institute$3,355,290
KL2 · FY2011 · RR · contact PI
CTSA INFRASTRUCTURE FOR AIDS RESEARCH$2,378,277
UL1 · FY2011 · RR · contact PI
CTSA INFRASTRUCTURE FOR AIDS RESEARCH$2,378,277
UL1 · FY2011 · RR · contact PI
CTSA INFRASTRUCTURE FOR PEDIATRIC CLINICAL TRIALS$480,983
UL1 · FY2011 · RR · contact PI
Clinical and Transtional Science Institute$352,013
TL1 · FY2011 · RR · contact PI
Clinical and Translational Science Institute$207,593
UL1 · FY2011 · RR · contact PI
Clinical and Translational Science Institute$17,959,064
UL1 · FY2010 · RR · contact PI
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS$8,081,579
UL1 · FY2010 · RR · contact PI
POINT: Platelet-Oriented Inhibition in New TIA$7,252,198
U01 · FY2010 · NS · contact PI
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCH$5,387,719
UL1 · FY2010 · RR · contact PI
Clinical and Translational Science Institute$3,351,561
KL2 · FY2010 · RR · contact PI
CTSA INFRASTRUCTURE FOR AIDS RESEARCH$1,975,497
UL1 · FY2010 · RR · contact PI
CTSA INFRASTRUCTURE FOR AIDS RESEARCH$1,975,497
UL1 · FY2010 · RR · contact PI
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS AND PEDIATRIC RESEARCH$538,772
UL1 · FY2010 · RR · contact PI
Clinical and Translational Science Institute$334,394
TL1 · FY2010 · RR · contact PI
Clinical and Translational Science Institute$18,848,944
UL1 · FY2009 · RR · contact PI
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS$8,626,007
UL1 · FY2009 · RR · contact PI
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCH$5,919,948
UL1 · FY2009 · RR · contact PI
POINT: Platelet-Oriented Inhibition in New TIA$5,172,341
U01 · FY2009 · NS · contact PI
Clinical and Translational Science Institute$3,540,378
KL2 · FY2009 · RR · contact PI
CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTE$2,790,526
KL2 · FY2009 · RR · contact PI
CTSA INFRASTRUCTURE FOR AIDS RESEARCH$2,022,527
UL1 · FY2009 · RR · contact PI
CTSA INFRASTRUCTURE FOR AIDS RESEARCH$2,022,526
UL1 · FY2009 · RR · contact PI
Clinical and Translational Science Institute$986,522
UL1 · FY2009 · RR · contact PI
Clinical and Translational Science Institute$599,933
UL1 · FY2009 · RR · contact PI
Clinical and Translational Science Institute$522,044
UL1 · FY2009 · RR · contact PI
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS AND PEDIATRIC RESEARCH$507,446
UL1 · FY2009 · RR · contact PI
CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTE: AIDS$374,926
KL2 · FY2009 · RR · contact PI
CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTE: AIDS$374,926
KL2 · FY2009 · RR · contact PI
Clinical and Translational Science Institute$338,806
TL1 · FY2009 · RR · contact PI
Clinical and Translational Science Institute$30,744
UL1 · FY2009 · RR · contact PI
Clinical and Translational Science Institute$18,941,306
UL1 · FY2008 · RR · contact PI
Clinical and Translational Science Institute$3,805,299
KL2 · FY2008 · RR · contact PI
Clinical and Translational Science Institute$326,236
TL1 · FY2008 · RR · contact PI
OPTIMIZING MANAGEMENT OF TRANSIENT ISCHEMIC ATTACKS$94,770
K02 · FY2005 · NS
OPTIMIZING MANAGEMENT OF TRANSIENT ISCHEMIC ATTACKS$94,770
K02 · FY2004 · NS
OPTIMIZING MANAGEMENT OF TRANSIENT ISCHEMIC ATTACKS$148,770
K02 · FY2003 · NS
OPTIMIZING MANAGEMENT OF TRANSIENT ISCHEMIC ATTACKS$148,770
K02 · FY2002 · NS
OPTIMIZING MANAGEMENT OF TRANSIENT ISCHEMIC ATTACKS$121,770
K02 · FY2001 · NS
ACUTE OUTCOME AFTER TRANSIENT ISCHEMIC ATTACKS$105,570
K08 · FY2000 · NS